Filing Details
Sarasin & Partners LLP, a registered investment adviser, reduced its position in Colgate-Palmolive Company (NYSE:CL) during Q2 2026, according to its most recent 13F filing with the Securities and Exchange Commission.
The firm sold 639,036 shares of the Consumer Defensive company, reducing its total holdings to 1,858,052 shares valued at approximately $170.3M as of the filing date. This represents a 25.6% decrease in the position.
Market Context
Colgate-Palmolive Company's stock currently trades at $92.80 with a market capitalization of $62.3B.
Institutional selling doesn't always signal a bearish outlook. Large funds regularly trim positions for portfolio rebalancing, client redemptions, or to lock in gains. That said, when a major holder like Sarasin & Partners LLP reduces exposure to Colgate-Palmolive Company, it's worth monitoring whether other institutions are making similar moves.
Colgate-Palmolive Company operates in the Consumer Defensive sector, where institutional ownership patterns can provide insight into how professional investors view the industry's near-term prospects.
The size of this position — $170.3 million — places it among the more significant institutional holdings in Colgate-Palmolive Company. Large positions like this can influence trading dynamics and are closely watched by market participants tracking smart money flows.
Investors should note that 13F filings reflect holdings as of the end of the reporting quarter and are filed up to 45 days later. The position may have changed since the filing date. 13F data is most useful when analyzed alongside other signals such as insider transactions, analyst ratings, and fundamental trends.
Related Tools: Insider Trades Tracker | View CL Stock Page
Frequently Asked Questions
What is a 13F filing?
A 13F filing is a quarterly SEC report required for institutional managers with over $100 million in assets. It discloses equity holdings, providing transparency into how firms like Sarasin & Partners LLP position their portfolios.
How can I track institutional ownership of CL?
View all institutional holders on our CL institutional ownership page.